Clinical Advances in Dentoalveolar Surgery
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Dentistry and Oral Health".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 14067
Special Issue Editor
Interests: oral implantology; dentoalveolar surgery; implant rehabilitation; prosthodontics; dental esthetics
Special Issue Information
Dear Colleagues,
The field of dentoalveolar surgery is rapidly evolving. The tremendous advances in the past decade in the areas of biomaterials and biotechnologies have set the premises to develop new surgical protocols, and to make the existing ones more predictable. Additionally, with the massive incorporation of digital technologies in daily practice, treatment planning and execution have become increasingly accurate. Therefore, we continuously need new scientific data to validate new protocols, to compare the outcomes with the current standard of care, to make all clinical decisions evidence based.
The aim of this Special Issue is to present an update in the field of dentoalveolar surgery, focusing on novel surgical protocols and new biomaterials and technological solutions to restore the anatomy and function of the jaws. Authors are encouraged to submit original studies, case series, systematic reviews and letters related, but not limited, to the following topics:
- Digital solutions for dental implant planning and placement;
- Surgical techniques for bone regeneration;
- Enhancement of soft tissue quality, quantity and esthetics;
- Implant-supported oral rehabilitation;
- Biomaterials for implants, tissue grafting or prosthetics;
- Partial extraction therapies and alveolar ridge preservation;
- Surgical techniques supporting other specialties, like orthodontics and endodontics.
Dr. Mihai Săndulescu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.